LORUS THERAPEUTICS INC.
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Aug 12, 2010 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 92 Total Citation Count
- Jun 30, 1997 Earliest Filing
- 17 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0204,305 SMALL INTERFERING RNA MOLECULES AGAINST RIBONUCLEOTIDE REDUCTASE AND USES THEREOFAbandonedFeb 04, 10Aug 12, 10[A61K, A61P]
2009/0118,205 Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and uses Thereof in the Treatment of CancerAbandonedAug 10, 05May 07, 09[A61K, C07H]
2008/0255,065 Small Interfering Rna Molecules Against Ribonucleotide Reductase and Uses ThereofAbandonedAug 18, 05Oct 16, 08[A61K, C07H, C12N, A61P]
2007/0274,947 Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1 and Uses Thereof in the Treatment of CancerAbandonedMay 21, 04Nov 29, 07[A61K, A61P]
7223849 Oligonucleotides from the untranslated regions of housekeeping genes and methods of using same to modulate cell growthExpiredJun 30, 97May 29, 07[C07H]
2007/0032,442 Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cellsAbandonedAug 08, 05Feb 08, 07[A61K, C07H]
7087580 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growthExpiredApr 22, 99Aug 08, 06[A01N]
2005/0192,443 Biological response modifier for the treatment of cancerAbandonedApr 08, 04Sep 01, 05[A61K, C07D]
2004/0198,819 Biological response modifier composition and uses thereofAbandonedMay 03, 04Oct 07, 04[A61K]
2004/0101,511 Combination preparation of a biological response modifier and an anticancer agent and uses thereofAbandonedJan 02, 04May 27, 04[A61K]
6610539 Antisense oligonucleotide sequences as inhibitors of microorganismsExpiredJul 09, 98Aug 26, 03[C07H, A61K, C12N]
6566514 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growthExpiredOct 18, 00May 20, 03[C07H, C12Q, C12P, C12N]
2003/0087,866 Suppression of malignancy utilizing ribonucleotide reductase R1AbandonedAug 20, 02May 08, 03[A61K, C12N]
6472376 Suppression of malignancy utilizing ribonucleotide reductase R1ExpiredSep 24, 98Oct 29, 02[A61K, C12N]
6417169 Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to inhibit cell growthExpiredApr 22, 99Jul 09, 02[C07H, A61K, C12Q, C12P, C12N]
6121000 Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductaseExpiredFeb 11, 99Sep 19, 00[C07H, C12Q, C12N]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
